CSF3 and graft versus host disease: G-CSF mobilized DLI (G-DLI) is especially appealing as previous studies have shown that G-CSF mobilized peripheral blood progenitor cell infusion leads to superior disease-free survival without increasing GVHD rates in relapsed patients [7, 8].